Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 48

1.

Effects of calcium concentration on nonviral gene delivery to bone marrow-derived stem cells.

Acri TM, Laird NZ, Geary SM, Salem AK, Shin K.

J Tissue Eng Regen Med. 2019 Nov 1. doi: 10.1002/term.2971. [Epub ahead of print]

PMID:
31677246
2.

Pentaerythritol-based lipid A bolsters the antitumor efficacy of a polyanhydride particle-based cancer vaccine.

Wafa EI, Geary SM, Ross KA, Goodman JT, Narasimhan B, Salem AK.

Nanomedicine. 2019 Oct;21:102055. doi: 10.1016/j.nano.2019.102055. Epub 2019 Jul 15.

PMID:
31319179
3.

Tissue Engineering for the Temporomandibular Joint.

Acri TM, Shin K, Seol D, Laird NZ, Song I, Geary SM, Chakka JL, Martin JA, Salem AK.

Adv Healthc Mater. 2019 Jan;8(2):e1801236. doi: 10.1002/adhm.201801236. Epub 2018 Dec 17. Review.

PMID:
30556348
4.

Single Dose of a Polyanhydride Particle-Based Vaccine Generates Potent Antigen-Specific Antitumor Immune Responses.

Wafa EI, Geary SM, Ross KA, Goodman JT, Narasimhan B, Salem AK.

J Pharmacol Exp Ther. 2019 Sep;370(3):855-863. doi: 10.1124/jpet.118.252809. Epub 2018 Oct 25.

PMID:
30361239
5.

Nanoparticle-Based Delivery of CRISPR/Cas9 Genome-Editing Therapeutics.

Givens BE, Naguib YW, Geary SM, Devor EJ, Salem AK.

AAPS J. 2018 Oct 10;20(6):108. doi: 10.1208/s12248-018-0267-9. Review.

6.

Nanoparticle-based CpG-oligonucleotide therapy for treating allergic asthma.

Givens BE, Geary SM, Salem AK.

Immunotherapy. 2018 Jun;10(7):595-604. doi: 10.2217/imt-2017-0142. Epub 2018 Mar 23. Review.

7.

Combining ultrasound and intratumoral administration of doxorubicin-loaded microspheres to enhance tumor cell killing.

Do AV, Geary SM, Seol D, Tobias P, Carlsen D, Leelakanok N, Martin JA, Salem AK.

Int J Pharm. 2018 Mar 25;539(1-2):139-146. doi: 10.1016/j.ijpharm.2018.01.028. Epub 2018 Jan 17.

8.

Synthetically lethal nanoparticles for treatment of endometrial cancer.

Ebeid K, Meng X, Thiel KW, Do AV, Geary SM, Morris AS, Pham EL, Wongrakpanich A, Chhonker YS, Murry DJ, Leslie KK, Salem AK.

Nat Nanotechnol. 2018 Jan;13(1):72-81. doi: 10.1038/s41565-017-0009-7. Epub 2017 Dec 4.

9.

Antitumor Efficacy and Toxicity of 5-Fluorouracil-Loaded Poly(Lactide Co-glycolide) Pellets.

Leelakanok N, Geary SM, Salem AK.

J Pharm Sci. 2018 Feb;107(2):690-697. doi: 10.1016/j.xphs.2017.10.005. Epub 2017 Oct 12.

10.

Running the Numbers: Understanding the Prevalence of Eye and Ear Injuries in North Carolina.

Geary SM, Cox ME, Proescholdbell SK.

N C Med J. 2017 Mar-Apr;78(2):134-137. doi: 10.18043/ncm.78.2.134. No abstract available.

11.

Surface-modified particles loaded with CaMKII inhibitor protect cardiac cells against mitochondrial injury.

Wongrakpanich A, Morris AS, Geary SM, Joiner MA, Salem AK.

Int J Pharm. 2017 Mar 30;520(1-2):275-283. doi: 10.1016/j.ijpharm.2017.01.061. Epub 2017 Feb 3.

12.

The effect of polyanhydride chemistry in particle-based cancer vaccines on the magnitude of the anti-tumor immune response.

Wafa EI, Geary SM, Goodman JT, Narasimhan B, Salem AK.

Acta Biomater. 2017 Mar 1;50:417-427. doi: 10.1016/j.actbio.2017.01.005. Epub 2017 Jan 4.

13.

Surface engineering tumor cells with adjuvant-loaded particles for use as cancer vaccines.

Ahmed KK, Geary SM, Salem AK.

J Control Release. 2017 Feb 28;248:1-9. doi: 10.1016/j.jconrel.2016.12.036. Epub 2017 Jan 3.

14.

Production of Adjuvant-Loaded Biodegradable Particles for Use in Cancer Vaccines.

de Barros CM, Wafa EI, Chitphet K, Ahmed K, Geary SM, Salem AK.

Methods Mol Biol. 2017;1494:201-213.

PMID:
27718195
15.

Bone Regeneration Using Gene-Activated Matrices.

D'Mello S, Atluri K, Geary SM, Hong L, Elangovan S, Salem AK.

AAPS J. 2017 Jan;19(1):43-53. doi: 10.1208/s12248-016-9982-2. Epub 2016 Sep 21. Review.

16.

Assessing the effect of engineered nanomaterials on the environment and human health.

Geary SM, Morris AS, Salem AK.

J Allergy Clin Immunol. 2016 Aug;138(2):405-8. doi: 10.1016/j.jaci.2016.06.009. Epub 2016 Jun 27. No abstract available.

17.

Size-dependent cytotoxicity of copper oxide nanoparticles in lung epithelial cells.

Wongrakpanich A, Mudunkotuwa IA, Geary SM, Morris AS, Mapuskar KA, Spitz DR, Grassian VH, Salem AK.

Environ Sci Nano. 2016 Apr 1;3(2):365-374. Epub 2016 Feb 24.

18.

Development and Evaluation of Biodegradable Particles Coloaded With Antigen and the Toll-Like Receptor Agonist, Pentaerythritol Lipid A, as a Cancer Vaccine.

Ahmed KK, Geary SM, Salem AK.

J Pharm Sci. 2016 Mar;105(3):1173-9. doi: 10.1016/j.xphs.2015.11.042. Epub 2016 Jan 30.

19.

Diaminosulfide based polymer microparticles as cancer vaccine delivery systems.

Geary SM, Hu Q, Joshi VB, Bowden NB, Salem AK.

J Control Release. 2015 Dec 28;220(Pt B):682-90. doi: 10.1016/j.jconrel.2015.09.002. Epub 2015 Sep 8.

20.

3D Printing of Scaffolds for Tissue Regeneration Applications.

Do AV, Khorsand B, Geary SM, Salem AK.

Adv Healthc Mater. 2015 Aug 26;4(12):1742-62. doi: 10.1002/adhm.201500168. Epub 2015 Jun 10. Review.

21.

Mitochondria-targeting particles.

Wongrakpanich A, Geary SM, Joiner ML, Anderson ME, Salem AK.

Nanomedicine (Lond). 2014 Nov;9(16):2531-43. doi: 10.2217/nnm.14.161. Review.

22.
23.

Applying biodegradable particles to enhance cancer vaccine efficacy.

Ahmed KK, Geary SM, Salem AK.

Immunol Res. 2014 Aug;59(1-3):220-8. doi: 10.1007/s12026-014-8537-9. Review.

PMID:
24838147
24.

Production of antigen-loaded biodegradable nanoparticles and uptake by dendritic cells.

Joshi VB, Geary SM, Salem AK.

Methods Mol Biol. 2014;1139:453-66. doi: 10.1007/978-1-4939-0345-0_35.

PMID:
24619699
25.

The absence of CpG in plasmid DNA-chitosan polyplexes enhances transfection efficiencies and reduces inflammatory responses in murine lungs.

Wongrakpanich A, Adamcakova-Dodd A, Xie W, Joshi VB, Mapuskar KA, Geary SM, Spitz DR, Thorne PS, Salem AK.

Mol Pharm. 2014 Mar 3;11(3):1022-31. doi: 10.1021/mp400689r. Epub 2014 Feb 4.

26.

Tumor lysate-loaded biodegradable microparticles as cancer vaccines.

Joshi VB, Geary SM, Gross BP, Wongrakpanich A, Norian LA, Salem AK.

Expert Rev Vaccines. 2014 Jan;13(1):9-15. doi: 10.1586/14760584.2014.851606. Review.

27.

Biodegradable particles as vaccine antigen delivery systems for stimulating cellular immune responses.

Joshi VB, Geary SM, Salem AK.

Hum Vaccin Immunother. 2013 Dec;9(12):2584-90. doi: 10.4161/hv.26136. Epub 2013 Aug 26. Review.

28.

The combination of a low-dose chemotherapeutic agent, 5-fluorouracil, and an adenoviral tumor vaccine has a synergistic benefit on survival in a tumor model system.

Geary SM, Lemke CD, Lubaroff DM, Salem AK.

PLoS One. 2013 Jun 28;8(6):e67904. doi: 10.1371/journal.pone.0067904. Print 2013.

29.

Prostate cancer vaccines: Update on clinical development.

Geary SM, Salem AK.

Oncoimmunology. 2013 May 1;2(5):e24523. Epub 2013 Apr 29.

30.

Proposed mechanisms of action for prostate cancer vaccines.

Geary SM, Lemke CD, Lubaroff DM, Salem AK.

Nat Rev Urol. 2013 Mar;10(3):149-60. doi: 10.1038/nrurol.2013.8. Epub 2013 Feb 12. Review.

31.

Antigen-coated poly ╬▒-hydroxy acid based microparticles for heterologous prime-boost adenovirus based vaccinations.

Lemke CD, Geary SM, Joshi VB, Salem AK.

Biomaterials. 2013 Mar;34(10):2524-9. doi: 10.1016/j.biomaterials.2012.12.030. Epub 2013 Jan 11.

32.

Characterizing the antitumor response in mice treated with antigen-loaded polyanhydride microparticles.

Joshi VB, Geary SM, Carrillo-Conde BR, Narasimhan B, Salem AK.

Acta Biomater. 2013 Mar;9(3):5583-9. doi: 10.1016/j.actbio.2012.11.001. Epub 2012 Nov 12.

33.

Biodegradable particles as vaccine delivery systems: size matters.

Joshi VB, Geary SM, Salem AK.

AAPS J. 2013 Jan;15(1):85-94. doi: 10.1208/s12248-012-9418-6. Epub 2012 Oct 10.

34.

Chitosan is a surprising negative modulator of cytotoxic CD8+ T cell responses elicited by adenovirus cancer vaccines.

Lemke CD, Graham JB, Geary SM, Zamba G, Lubaroff DM, Salem AK.

Mol Pharm. 2011 Oct 3;8(5):1652-61. doi: 10.1021/mp100464y. Epub 2011 Aug 9.

35.

Tumor immunotherapy using adenovirus vaccines in combination with intratumoral doses of CpG ODN.

Geary SM, Lemke CD, Lubaroff DM, Salem AK.

Cancer Immunol Immunother. 2011 Sep;60(9):1309-17. doi: 10.1007/s00262-011-1038-y. Epub 2011 May 28.

36.

Nanoparticle delivery systems in cancer vaccines.

Krishnamachari Y, Geary SM, Lemke CD, Salem AK.

Pharm Res. 2011 Feb;28(2):215-36. doi: 10.1007/s11095-010-0241-4. Epub 2010 Aug 19. Review.

37.

The role of the tetraspanin CD151 in primary keratinocyte and fibroblast functions: implications for wound healing.

Geary SM, Cowin AJ, Copeland B, Baleato RM, Miyazaki K, Ashman LK.

Exp Cell Res. 2008 Jul 1;314(11-12):2165-75. doi: 10.1016/j.yexcr.2008.04.011. Epub 2008 May 3.

PMID:
18534576
38.

Early myeloid cells expressing c-KIT isoforms differ in signal transduction, survival and chemotactic responses to Stem Cell Factor.

Young SM, Cambareri AC, Odell A, Geary SM, Ashman LK.

Cell Signal. 2007 Dec;19(12):2572-81. Epub 2007 Aug 15.

PMID:
17855052
39.

Wound healing is defective in mice lacking tetraspanin CD151.

Cowin AJ, Adams D, Geary SM, Wright MD, Jones JC, Ashman LK.

J Invest Dermatol. 2006 Mar;126(3):680-9.

40.

Characterization of mice lacking the tetraspanin superfamily member CD151.

Wright MD, Geary SM, Fitter S, Moseley GW, Lau LM, Sheng KC, Apostolopoulos V, Stanley EG, Jackson DE, Ashman LK.

Mol Cell Biol. 2004 Jul;24(13):5978-88.

41.

Differential tissue expression of epitopes of the tetraspanin CD151 recognised by monoclonal antibodies.

Geary SM, Cambareri AC, Sincock PM, Fitter S, Ashman LK.

Tissue Antigens. 2001 Sep;58(3):141-53.

PMID:
11703821
42.

Osteoprotegerin inhibits osteoclast formation and bone resorbing activity in giant cell tumors of bone.

Atkins GJ, Bouralexis S, Haynes DR, Graves SE, Geary SM, Evdokiou A, Zannettino AC, Hay S, Findlay DM.

Bone. 2001 Apr;28(4):370-7.

PMID:
11336917
43.

Coordinated cytokine expression by stromal and hematopoietic cells during human osteoclast formation.

Atkins GJ, Haynes DR, Geary SM, Loric M, Crotti TN, Findlay DM.

Bone. 2000 Jun;26(6):653-61.

PMID:
10831938
44.

Bidirectional signaling between stromal and hemopoietic cells regulates interleukin-1 expression during human osteoclast formation.

Haynes DR, Atkins GJ, Loric M, Crotti TN, Geary SM, Findlay DM.

Bone. 1999 Sep;25(3):269-78.

PMID:
10495130
45.

CA125 phosphorylation is associated with its secretion from the WISH human amnion cell line.

Fendrick JL, Konishi I, Geary SM, Parmley TH, Quirk JG Jr, O'Brien TJ.

Tumour Biol. 1997;18(5):278-89.

PMID:
9276028
47.

Nursing management of cranial nerve dysfunction.

Geary SM.

J Neurosci Nurs. 1995 Apr;27(2):102-8.

PMID:
7622946
48.

Supplemental Content

Loading ...
Support Center